Poseida Therapeutics, Inc.: SCHEDULE 13G/A filed Feb 7, 2025

Form type

SCHEDULE 13G/A

Filing date

Feb 7, 2025

Accession number

0000315066-25-000429

Filer

Poseida Therapeutics, Inc. (CIK 1661460)